WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005034930) PELLETS CONTAINING VENLAFAXINE HYDROCHLORIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/034930    International Application No.:    PCT/HU2004/000095
Publication Date: 21.04.2005 International Filing Date: 08.10.2004
Chapter 2 Demand Filed:    21.04.2005    
IPC:
A61K 9/16 (2006.01), A61K 31/137 (2006.01), A61K 47/02 (2006.01), A61K 47/38 (2006.01)
Applicants: EGIS GYÓGYSZERGYÁR RT. [HU/HU]; Keresztúri út 30-38, H-1106 Budapest (HU) (For All Designated States Except US).
FEKETE, Pál [HU/HU]; (HU) (For US Only).
KORBÉLY, Tibor [HU/HU]; (HU) (For US Only).
BOZSÓ, Ágnes [HU/HU]; (HU) (For US Only).
MÓRICZ, Eszter [HU/HU]; (HU) (For US Only)
Inventors: FEKETE, Pál; (HU).
KORBÉLY, Tibor; (HU).
BOZSÓ, Ágnes; (HU).
MÓRICZ, Eszter; (HU)
Agent: ADVOPATENT OFFICE OF PATENT AND TRADEMARK ATTORNEYS; P.O. Box 11, H-1251 Budapest (HU)
Priority Data:
P 0303382 10.10.2003 HU
Title (EN) PELLETS CONTAINING VENLAFAXINE HYDROCHLORIDE
(FR) GRANULES CONTENANT DU CHLORHYDRATE DE VENLAFAXINE
Abstract: front page image
(EN)The invention relates to pellets containing venlafaxine hydrochloride and a process for the preparation thereof. The pellets according to the invention are nearly spherical in shape and comprise pharmaceutically active venlafaxine hydro­chloride in an amount of at most 80 % by weight, furthermore 10 to 60 % by weight of sodium chloride and/or potassium chloride, 10 to 60 % by weight of microcrystalline cellulose and optionally other pharmaceutically acceptable excipients and/or pelletization promoting additives. Said pellets are particularly suitable to be coated with a layer ensuring a controlled release of the active ingredient.
(FR)L'invention concerne des granulés contenant du chlorhydrate de venlafaxine et leur procédé de préparation. Ces granulés sont quasiment sphériques et contiennent 80 % en masse, tout au plus, de chlorhydrate de venlafaxine de qualité pharmaceutique, 10 à 60 % en masse de chlorure de sodium et/ou de potassium, 10 à 60 % en masse de cellulose microcristalline et éventuellement d'autres excipients et/ou additifs favorisant l'agrégation de qualité pharmaceutique. Ces granulés sont tout particulièrement conçus pour être enduits d'une couche assurant une libération contrôlée de l'ingrédient actif.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)